AddLife (ALIF B.ST) Delnica Cena
AddLife Cena
Prihodki so rasli 20,7 % letno v zadnjih 13 letih na 10,44 Mrd. SEK. Dobiček na delnico je rasel 16,9 % letno v zadnjih 13 letih. čista marža družbe AddLife je zdaj 5,4 %, padla z 9,0 % pred nekaj leti. AddLife trenutno ponuja dividendno donosnost okoli 0,42 %. Izplačilni delež je okoli 16 % dobička. Dividenda je rasla 9,1 % letno v zadnjih 8 letih. Mediana ciljne cene analitikov je 218,28 SEK, torej nad trenutno ceno za 21,1 %. Od 8 analitikov jih 5 priporoča nakup — skupni konsenz je Nakup.
Cena delnice AddLife
Do teh podatkov prek Eulerpool API
100.000 zahtevkov/mes. brezplačno · brez kartice
AddLife poslovni model in analiza delnice
Pogosto postavljena vprašanja o delnici AddLife
The business model of AddLife AB revolves around the distribution and marketing of high-quality products and services within the life science sector. AddLife AB primarily focuses on three business areas: Labtech, Medtech, and Diagnostics. Labtech involves offering innovative solutions, including equipment and consumables, to laboratories and research institutions. Medtech includes the distribution of medical technology products for healthcare and rehabilitation. Diagnostics encompasses the supply of diagnostic products and services for medical laboratories. AddLife AB aims to provide its customers with comprehensive solutions, strong expertise, and reliable deliveries to meet their needs in the life science industry.
AddLife AB is primarily active in the industries of life sciences and healthcare.
The main competitors of AddLife AB in the market are its industry peers, such as Getinge AB, Lifco AB, and Elekta AB.
AddLife AB is a Swedish company specializing in the distribution and sales of high-quality products for the healthcare sector. Founded in 2016, AddLife has quickly become a leading player in the Nordic region, providing services and solutions within the fields of laboratory equipment, diagnostics, and biotechnology. The company focuses on areas such as research, healthcare, and life science, offering a wide range of products from renowned global manufacturers. With its extensive expertise and strong market presence, AddLife continues to evolve and expand its operations, driving advancements in healthcare and contributing to the well-being of individuals and society as a whole.
AddLife AB, a leading company in the life science sector, has achieved several notable milestones. The company has successfully expanded its presence and market share, becoming a key player in the industry. AddLife AB has made strategic acquisitions, enhancing its product portfolio and geographical reach. Additionally, it has formed collaborations with renowned partners, reinforcing its position as an innovative and reliable partner in the life science field. The company's steadfast commitment to customer satisfaction and focus on delivering high-quality products and services have contributed to its continued success and growth. AddLife AB's dedication to excellence has led to significant achievements and recognition within the life science industry.
AddLife AB is primarily present in Sweden and Finland.
AddLife AB is a leading company that represents strong values and a robust corporate philosophy. They prioritize customer satisfaction and strive to deliver exceptional products and services. AddLife AB values integrity, professionalism, and continuous improvement in everything they do. With a focus on innovation and sustainability, the company aims to create long-term value for both stakeholders and society as a whole. By providing high-quality healthcare solutions and fostering partnerships, AddLife AB demonstrates their commitment to improving people's lives.
Analitiki trenutno določajo povprečno ciljno ceno 208,59 SEK za delnico AddLife (mediana: 218,28 SEK), kar pomeni +14,4 % glede na zadnjo ceno. Konsenz temelji na 8 ocenah.
8 analitikov trenutno ocenjuje delnico AddLife: 5 priporoča nakup, 3 držanje in 0 prodajo. Za 2026 analitiki pričakujejo, da bo AddLife ustvaril prihodke 10,90 Mrd. SEK in dobiček na delnico 6,28 SEK.
Po trenutnem tečaju se delnica AddLife trguje po 16,46 EUR (180,20 SEK).
Delnica AddLife (ALIF B.ST) je uvrščena na 6 borzah, med njimi: London (0REZ.L), Frankfurt (1AD1.F), München (1AD1.MU), Stockholm (ALIF B.ST).
The Swedish company AddLife AB is a B2B company that offers products and solutions for the healthcare sector. The company focuses on four main business areas: Life Science, Labtech, Medtech, and Healthcare. AddLife offers its customers a wide range of products, services, and solutions in these areas. In the Life Science area, AddLife offers products and solutions for the research and development of pharmaceutical and biotechnology companies. This includes, for example, analysis instruments, laboratory equipment and chemicals, as well as consumables. The Labtech area specializes in laboratory equipment. This includes, for example, workstations, technical systems, and consumables. Software solutions for the execution and evaluation of experiments are also part of the offer. In the Medtech area, AddLife offers products and solutions for diagnostics and therapy. This includes, for example, instruments for cardiology or laboratory medicine, as well as consumables for medical examinations. Special products for infection control are also offered. In the Healthcare area, AddLife offers products and solutions for nursing and rehabilitation. This includes, for example, aids for mobility promotion, products for wound care or incontinence care. AddLife does not sell its products and solutions directly to end customers, but to companies and institutions in the healthcare sector such as hospitals, practices, or research institutes. AddLife follows a clear strategy to expand and develop its business. This includes, for example, acquisitions, cooperations, and networking. This way, AddLife can expand its product portfolio and use the expertise of its partners. The internationalization of the business also plays an important role. AddLife is already active in several countries worldwide and plans to further expand its business. The business model of AddLife is based on long-term customer relationships and a high quality of products and services. AddLife works closely with its customers and offers them customized solutions. Customers can benefit from the extensive experience and expertise of AddLife. In summary, AddLife is an innovative and future-oriented company that offers products and solutions for the healthcare sector. Through its clear strategy, high quality products and services, and collaboration with partners and customers, AddLife aims to further expand its business and strengthen its position in the market.
pričakovane prihodki za AddLife znašajo 10,90 Mrd. SEK. Ta vrednost temelji na trenutnih finančnih podatkih in odraža poslovno uspešnost podjetja.
pričakovane dobiček za AddLife znaša 765,18 Mio. SEK. Čisti dobiček odraža donosnost podjetja po odbitku vseh stroškov.
Razmerje cena-dobiček (P/E) AddLife je trenutno 28,70. Razmerje P/E primerja trenutno ceno delnice z dobičkom na delnico in pomoči vlagateljem oceniti vrednost delnice AddLife.
Razmerje cena-prihodki (P/S) AddLife je trenutno 2,02. Razmerje P/S primerja tržno vrednost s celotnimi letnimi prihodki in služi kot kazalnik vrednotenja delnice AddLife.
Eulerpool ocena kvalitete za AddLife je 4/10.
ISIN AddLife je SE0014401378. ISIN (International Securities Identification Number) je svetovni edinstven identifikator za vrednostne papirje.
WKN AddLife je A2P4TH. WKN (Wertpapierkennnummer) je šestmestna nemška oznaka za identifikacijo vrednostnih papirjev.
Ticker AddLife je ALIF B.ST. Ticker simbol se uporablja za trgovanje z delnicami AddLife na borzi.
AddLife delnica
Vse ključne kazalnike in poglobljeno analizo AddLife v detaljnem pregledu
Naša analiza delnic AddLife vključuje pomembne finančne kazalnike, kot so prihodki, dobiček, razmerje cena/dobiček (P/E), razmerje cena/prihodki (P/S), EBIT ter informacije o dividendah. Prav tako preučujemo aspekte, kot so delnice, tržna kapitalizacija, dolgovi, lastniški kapital in obveznosti AddLife. Če iščete podrobnejše informacije o teh temah, na naših podstraneh nudimo obsežne analize: